活跃的炎症性肠病和遗传性α-tryptasemia的个体的消化道中MRGPRX2-表达性瘤细胞增加
Michelle Galeas-Pena1, Jonathan J Lyons2,3, Dhana Llivichuzhca-Loja4
1Department of Medicine, Section of Gastroenterology. Tulane University School of Medicine. New Orleans, LA.
medRxiv : the preprint server for health sciences
|January 8, 2026
概括
遗传性α-tryptasemia (HαT) 与更多的巨细胞和肠道活性增加有关,特别是在炎症性肠病 (IBD) 中. 这表明巨细胞激活在与HαT相关的胃肠道问题中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
背景情况:
- 遗传性α-tryptasemia (HαT) 涉及增加TPSAB1拷贝数和血清酸酶的升高,与巨细胞 (MC) 介导的症状有关.
- 在胃肠道疾病,特别是炎症性肠病 (IBD) 中HαT的作用尚不清楚.
- 肠道MCs表达MRGPRX2,一种非IgE依赖的激活受体,这表明它可能参与与HαT相关的肠道问题.
研究的目的:
- 研究HαT和IBD患者MRGPRX2表达的变化.
- 为了确定HαT和胃肠道中巨细胞激活标志物之间的关联.
- 探索增强的MRGPRX2表达和MC激活对HαT中胃肠道症状的潜在贡献,特别是在IBD的背景下.
主要方法:
- 854个IBD样本的基因定型用于识别HαT.
- 来自HαT和非HαTIBD个体的下降结肠组织的空间转录学.
- 来自HαT患者和对照者的小肠活检的质量细胞计 (CyTOF) 分析.
主要成果:
- HαT与胃肠道MC丰度增加和激活标志物 (CD203c,LAMP-1,SIGLEC8) 的更高表达相关.
- 从HαT患者的IBD样本中观察到显著增加的MRGPRX2和SIGLEC8转录,与非HαTIBD病例相比.
- 这些发现在空间转录学和ddPCR分析中是一致的.
结论:
- 增强的MRGPRX2表达和巨细胞激活可能会导致遗传性α-tryptasemia的胃肠道症状,特别是在IBD患者中.
- 定义与α-酸酶拷贝数相关的MC表型可以帮助完善诊断评估.
- 这项研究可能有助于识别那些可能受益于IBD新型乳腺细胞向治疗的患者.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
871
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
871
Chronic Bowel Disorders: Introduction
743
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
743
Irritable Bowel Syndrome I: Introduction
910
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
910


